Phospholipase D2 (PLD2) (N-Term) Peptid
PLD2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Phospholipase D2 (PLD2) Produkte
- Phospholipase D2 (PLD2)
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PLD2 antibody (Catalog #: ARP38182_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Phospholipase D2 (PLD2)
- Synonyme
- Pldc Peptide, PLD2 Peptide, phospholipase D2 Peptide, PLD2 Peptide, Pld2 Peptide, pld2 Peptide, CpipJ_CPIJ013122 Peptide, VDBG_00892 Peptide
- Hintergrund
-
Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-14 AF033850.1 61-74 15-614 BC015033.1 1-600 615-1279 BC056871.1 549-1213 1280-1830 BC015033.1 1266-1816 1831-1995 BC056871.1 1765-1929 1996-3489 BC015033.1 1982-3475
Alias Symbols: -
Protein Interaction Partner: EGFR,PLCG1,ACTB,ACTN1,ALDOA,ALDOC,AMPH,AQP3,ARF1,BIN1,CAV1,CSK,DPYSL2,EGFR,FYN,GAPDH,GM2A,LCK,MTOR,OPRM1,PEA15,PIP5K1A,PLCG1,PRKCA,PRKCD,RPTOR,STXBP1,ALDOA,AMPH,AQP3,ARF1,Actb,BIN1,CAV1,CAV2,EGFR,GAPDH,MTOR,OPRM1,PEA15,PLCG1,PRKCA,PRKCD,RPTOR,SRC
Protein Size: 933 - Molekulargewicht
- 106 kDa
- Gen-ID
- 5338
- NCBI Accession
- NM_002663, NP_002654
- UniProt
- O14939
-
Sie sind hier:
